• Donations
  In our society, there are more than 40,000 people with genetic intellectual disabilities (30,000 with Down´s syndrome, 10,000 with Fragile X syndrome, and 2,500 with Williams Beuren syndrome). At present, however, no effective pharmacological treatments to alleviate these disabilities are available. At the Grup de Recerca Clínica en Farmacologia Humana i Neurociències of the IMIM, we are conducting a number of clinical studies in conjunction with the Centre for Genomic Regulation (CRG) which we believe could make a decisive contribution to improving the quality of life of individuals with these disabilities.

e-mail: [email protected] :: 2012-2016© cridard.imim.es :: Legal notice and privacy policy.